The company says it made a net loss of $12.6m, or $0.19 per share in the last three months of the year. That compares to a net loss of $21.6m, or $0.35 per share, a year earlier.
Overall, the company says product gross profits and gross margins improved throughout 2008.
The improvement is due primarily to growth in animal enzyme sales and margin improvement in other products, the company says.
Even
